Position in CBDL
as of Mar 31, 2022
· filed Aug 8, 2022
Position Value
$59
+$1 QoQ
Shares Held
992
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Mar 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBDL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in CBDL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2022-03-31 | $59 | 297,600 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $58 | 295,000 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $88 | 295,000 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $147 | 295,000 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $619 | 295,000 | Shares | Sole | 2021-04-30 | |
| No filing history on record for this holder in this stock. | ||||||